Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2017

Mar 1, 2017

284_dirs_2017-03-01_d1b0cb5b-5ee7-4293-8222-378844702a73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-02-27

Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-07 Common Stock G 10125.0000 $0.0000 Disposed 498752.0630 Direct
2017-02-27 Common Stock A 101552.0000 $65.8500 Acquired 600304.0630 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 3780.8102 Indirect

Footnotes

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/14. Performance shares were paid out at 158 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2016.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: Includes shares acquired and dividends earned through January 9, 2017, in the Merck U.S. Savings Plan, a 401(k) plan.